Header Logo

Connection

ERIC SCHAFER to Everolimus

Back to Details
This is a "connection" page, showing publications ERIC SCHAFER has written about Everolimus.
ERIC SCHAFER
Connection Strength
0.060
Everolimus
  1. ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma. Pediatr Blood Cancer. 2026 Nov; 73(11):e70662.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.